101 results on '"Van den Berge D"'
Search Results
2. From Linac to Tomotherapy: New Possibilities for Cure?
3. P04.03 Radiotherapy for subependymal giant cell astrocytoma: time to challenge a historical ban? Case report and review of the literature
4. Frameless multimodality image integration using vessel tree segmentation for stereotactic targeting of AVM
5. Hogeprecisieradiotherapie bij het prostaatcarcinoom
6. Late abstracts 186–187
7. Hypoxic radioresistance of tumor cells is sustained by M2 macrophages but can be counteracted by M1 activation resulting in nitric oxide-induced oxygen sparing
8. Nitric oxide-producing hepatocytes radiosensitize hypoxic colorectal cancer cells through oxygen sparing
9. PD-0235: Frameless multimodality image integration using vessel tree segmentation for stereotactic targeting of AVM
10. Expanded CD8+ T cells reveal radiosensitizing effects in tumor-relevant hypoxia: A link between immunostimulation and radiosensitization
11. Th1-type immunostimulation of murine splenocytes results in paracrine secretion of IFN-Gamma and hypoxic tumor cell radiosensitization
12. Activated CD8+T cells radiosensitize EMT-6 mammary carcinoma cells through secretion of interferon-gamma
13. Activated T cells possess both killer and radiosensitizing properties in mixed cultures with tumor cells
14. Activated CD8+ T cells radiosensitize EMT-6 mammary carcinoma cells through the interferon-gamma/iNOS pathway
15. Modulation of tumor cell radiosensitivity by native immune cells: the role of interferon-a in iNOS mediated radiosensitization
16. Activated immune cells radiosensitize tumour cells through the induction of NO synthesis: a novel role for the inflammatory tumour infiltrate in tumour cell radioresponse
17. Activated macrophages restore the radioresponse of hypoxic tumor cells: a role for IFN-gamma in iNOS-mediated radiosensitization
18. Hogeprecisieradiotherapie bij het prostaatcarcinoom
19. Immunomodulator lipid A may indirectly radiosensitize EMT-6 cancer cells through macrophages: a novel role for immune cells in cancer cell radioresponse
20. The role of COX-2 and iNOS in lipid A induced radiosensitization
21. Lipid A radiosensitizes hypoxic EMT-6 tumor cells: role of the NF-B signaling pathway
22. Lipid A radiosensitizes hypoxic EMT-6 tumour cells through the NF-kB signaling pathway
23. Immunomodulator lipid A may directly increase the radioresponse of hypoxic tumor cells
24. Nuclear factor-B is involved in the activation of iNOS by lipid A and in NO mediated radiosensitization
25. Proteasome inhibitor lactacystin has a dual effect on the radiosensitivity of EMT-6 tumour cells
26. NF-B inhibition impairs the radioresponse of hypoxic EMT-6 tumor cells through down-regulation of inducible nitric oxide synthase
27. The role of transcription factor NF-B in cellular radioresponse. A new hypothesis!
28. Proteasome inhibitor lactacystin impairs the radioresponse of hypoxic EMT-6 tumour cells: implications for NF-B inhibition
29. Le facteur de transcription NF-B joue un rôle important dans l’activation de la NO synthase inductible en hypoxie et peut ainsi influencer la radiosensibilité des cellules tumorales
30. Transcription factor NF-kappaB is involved in activation of inducible nitric oxide synthase in chronic hypoxia and nitric oxide-mediated radiosensitization
31. Métastases thyroïdiennes, présentation clinique et traitement
32. he role of NF-B in cellular radioresponse: conflicting evidence
33. Chronic hypoxia may increase hypoxic cell radiosensitivity through up-regulation of cytokine-inducible nitric oxide synthase
34. Therapeutic implementation of a PACS environment: multidisciplinary approach for radiotherapy
35. OC-0386 NITRIC OXIDE-PRODUCING HEPATOCYTES RADIOSENSITIZE HYPOXIC COLORECTAL CANCER CELLS THROUGH OXYGEN SPARING
36. P2-17-08: rospective Study of Aromatase Inhibitor Induced Bone Loss and Lipid Levels in Early Postmenopausal (PM) Hormone Receptor Positive (HR+) Breast Cancer (BC) Patients Treated with Adjuvant Letrozole Extended beyond 5 Years (yrs).
37. 5'-Nor-anhydrovinblastine (Navelbine®) has an anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro and in vivo
38. P52 Activated CD8+ T cells radiosensitize EMT-6 mammary carcinoma cells through secretion of interferon-gamma
39. Stereotactic Fractionated Radiotherapy (SRT) for Intra-Thoracic Tumours
40. Short-course stereotactic radiotherapy with high fraction doses for advanced intra-abdominal malignancies
41. NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase
42. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for glioblastoma: Results of EORTC 22933
43. PP66. Using appropriate comparators in economic evaluations: An exercise for Belgium
44. Impact of anatomical varlability on dose delivery by three field technique in adjuvant radiotherapy of breast cancer
45. Reversing potential of brefeldin A in non-P-glycoprotein mediated cellular resistance to adriamycin
46. NF-kappaB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase.
47. NF-κB inhibition impairs the radioresponse of hypoxic EMT-6 tumour cells through downregulation of inducible nitric oxide synthase.
48. Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside.
49. Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.
50. The effective atomic number and the calculation of the composition of phantom materials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.